These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Safety and efficacy of nesiritide in pediatric heart failure. Jefferies JL; Price JF; Denfield SW; Chang AC; Dreyer WJ; McMahon CJ; Grenier MA; Clunie SK; Thomas A; Moffett BS; Wann TS; Smith EO; Towbin JA J Card Fail; 2007 Sep; 13(7):541-8. PubMed ID: 17826644 [TBL] [Abstract][Full Text] [Related]
8. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695 [TBL] [Abstract][Full Text] [Related]
9. Predictors of worsening renal function in adult patients with congestive heart failure receiving recombinant human B-type brain natriuretic peptide (nesiritide). Iglesias J; Hom D; Antoniotti M; Ayoub S; Levine JS Nephrol Dial Transplant; 2006 Dec; 21(12):3458-65. PubMed ID: 16877484 [TBL] [Abstract][Full Text] [Related]
10. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study. Chen HH; Sundt TM; Cook DJ; Heublein DM; Burnett JC Circulation; 2007 Sep; 116(11 Suppl):I134-8. PubMed ID: 17846293 [TBL] [Abstract][Full Text] [Related]
11. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial. Mahesh B; Yim B; Robson D; Pillai R; Ratnatunga C; Pigott D Eur J Cardiothorac Surg; 2008 Mar; 33(3):370-6. PubMed ID: 18243724 [TBL] [Abstract][Full Text] [Related]
12. No change in B-type natriuretic peptide levels assessed in the late postoperative period in patients with severe mitral regurgitation after mitral valve surgery. Krishnaswami A; Jang JJ; Berkheimer S; Pompili M; Lee H Interact Cardiovasc Thorac Surg; 2011 May; 12(5):768-71. PubMed ID: 21343155 [TBL] [Abstract][Full Text] [Related]
13. Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study. Meco M; Cirri S; Gallazzi C; Magnani G; Cosseta D Eur J Cardiothorac Surg; 2007 Aug; 32(2):319-25. PubMed ID: 17574858 [TBL] [Abstract][Full Text] [Related]
14. Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients. Brackbill ML; Stam MD; Schuller-Williams RV; Dhavle AA Ann Pharmacother; 2007 Mar; 41(3):427-32. PubMed ID: 17311834 [TBL] [Abstract][Full Text] [Related]
17. Perioperative effects and safety of nesiritide following cardiac surgery in children. Simsic JM; Scheurer M; Tobias JD; Berkenbosch J; Schechter W; Madera F; Weinstein S; Michler RE J Intensive Care Med; 2006; 21(1):22-6. PubMed ID: 16698741 [TBL] [Abstract][Full Text] [Related]
18. Modulation of novel cardiorenal and inflammatory biomarkers by intravenous nitroglycerin and nesiritide in acute decompensated heart failure: an exploratory study. Chow SL; O'Barr SA; Peng J; Chew E; Pak F; Quist R; Patel P; Patterson JH; Heywood JT Circ Heart Fail; 2011 Jul; 4(4):450-5. PubMed ID: 21576282 [TBL] [Abstract][Full Text] [Related]
19. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide. Kurien S; Warfield KT; Wood CM; Miller WL Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223 [TBL] [Abstract][Full Text] [Related]
20. Effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children. Costello JM; Backer CL; Checchia PA; Mavroudis C; Seipelt RG; Goodman DM J Thorac Cardiovasc Surg; 2005 Sep; 130(3):822-9. PubMed ID: 16153935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]